1. Home
  2. CLDI vs RAYA Comparison

CLDI vs RAYA Comparison

Compare CLDI & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.39

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$2.29

Market Cap

2.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDI
RAYA
Founded
2014
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CLDI
RAYA
Price
$1.39
$2.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
88.3K
33.2K
Earning Date
05-14-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,000.00
N/A
Revenue This Year
N/A
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.03
52 Week High
$1.93
$10.14

Technical Indicators

Market Signals
Indicator
CLDI
RAYA
Relative Strength Index (RSI) 60.66 44.02
Support Level $1.29 $2.11
Resistance Level $1.42 $2.86
Average True Range (ATR) 0.11 0.08
MACD -0.05 0.01
Stochastic Oscillator 39.39 25.38

Price Performance

Historical Comparison
CLDI
RAYA

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

Share on Social Networks: